About 10% of the U.S. population fits into the highest-risk category, with a 20% or higher risk of a cardiac event; 54% are ...

Experts urge cardiologists to routinely screen for substance use, noting its independent impact on atherosclerotic risk and ...

BioAge’s NLRP3 inhibitor has shown potential to reduce high-sensitivity C-reactive protein (hsCRP), a key marker of ...

The American College of Cardiology found uneven gains and sobering declines in heart health. "You can't treat your way out of ...

The American College of Cardiology issued its inaugural JACC Cardiovascular Statistics report, highlighting the prevalence of ...

A nearly 30-year study shows a strong long-term association between very high lipoprotein(a) levels and cardiovascular ...

Brigham and Women's Hospital investigators link very high lipoprotein(a) with a higher 30-year risk of major cardiovascular ...

Discover how cardiovascular risk scores can indicate future eye disease risk. Keep reading to learn how to protect vision.

Common OTC painkillers like ibuprofen may increase heart attack and stroke risk. Learn which medications pose the greatest ...

Currently available therapies such as niacin and PCSK9 inhibitors such as Repatha (evolocumab) and Praluent (alirocumab) can reduce Lp (a) levels, but their impact is modest. Another challenge in ...

Very high Lp(a) also correlated with higher risks of ischemic stroke and cardiovascular mortality in the Women’s Health Study ...

Investigators sought to evaluate changes in the estimated CV risk of men with prostate cancer after 6 months of hormone therapy using clinical tools established for the general population. A post-hoc ...